871 related articles for article (PubMed ID: 34515857)
21. Indications for and contraindications of immune checkpoint inhibitors in cancer patients with COVID-19 vaccination.
Luo B; Li J; Hou X; Yang Q; Zhou Y; Ye J; Wu X; Feng Y; Hu T; Xu Z; He Y; Sun J
Future Oncol; 2021 Sep; 17(26):3477-3484. PubMed ID: 34189948
[TBL] [Abstract][Full Text] [Related]
22. COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials.
Desai A; Gainor JF; Hegde A; Schram AM; Curigliano G; Pal S; Liu SV; Halmos B; Groisberg R; Grande E; Dragovich T; Matrana M; Agarwal N; Chawla S; Kato S; Morgan G; Kasi PM; Solomon B; Loong HH; Park H; Choueiri TK; Subbiah IM; Pemmaraju N; Subbiah V;
Nat Rev Clin Oncol; 2021 May; 18(5):313-319. PubMed ID: 33723371
[TBL] [Abstract][Full Text] [Related]
23. Cardiac Complications More Common After COVID-19 Than Vaccination.
Kuehn BM
JAMA; 2022 May; 327(20):1951. PubMed ID: 35608572
[No Abstract] [Full Text] [Related]
24. COVID-19 vaccines and cancer patients: acceptance, attitudes and safety.
Matovina Brko G; Popovic M; Jovic M; Radic J; Bodlovic Kladar M; Nikolic I; Vidovic V; Kolarov Bjelobrk I; Kukic B; Salma S; Litavski J; Petrovic N; Vranjkovic B; Roganovic T; Ruzic M; Dugandzija T; Popovic L
J BUON; 2021; 26(5):2183-2190. PubMed ID: 34761633
[TBL] [Abstract][Full Text] [Related]
25. Mini Review Immunological Consequences of Immunization With COVID-19 mRNA Vaccines: Preliminary Results.
Lombardi A; Bozzi G; Ungaro R; Villa S; Castelli V; Mangioni D; Muscatello A; Gori A; Bandera A
Front Immunol; 2021; 12():657711. PubMed ID: 33777055
[No Abstract] [Full Text] [Related]
26. Benefit-risk evaluation of COVID-19 vaccination in special population groups of interest.
Moss P; Berenbaum F; Curigliano G; Grupper A; Berg T; Pather S
Vaccine; 2022 Jul; 40(32):4348-4360. PubMed ID: 35718592
[TBL] [Abstract][Full Text] [Related]
27. The Advisory Committee on Immunization Practices' Interim Recommendations for Additional Primary and Booster Doses of COVID-19 Vaccines - United States, 2021.
Mbaeyi S; Oliver SE; Collins JP; Godfrey M; Goswami ND; Hadler SC; Jones J; Moline H; Moulia D; Reddy S; Schmit K; Wallace M; Chamberland M; Campos-Outcalt D; Morgan RL; Bell BP; Brooks O; Kotton C; Talbot HK; Lee G; Daley MF; Dooling K
MMWR Morb Mortal Wkly Rep; 2021 Nov; 70(44):1545-1552. PubMed ID: 34735422
[TBL] [Abstract][Full Text] [Related]
28. To Be or Not To Be Vaccinated: That Is a Question in Myasthenia Gravis.
Zhou Q; Zhou R; Yang H; Yang H
Front Immunol; 2021; 12():733418. PubMed ID: 34603311
[TBL] [Abstract][Full Text] [Related]
29. COVID-19 vaccines and decreased transmission of SARS-CoV-2.
Vitiello A; Ferrara F; Troiano V; La Porta R
Inflammopharmacology; 2021 Oct; 29(5):1357-1360. PubMed ID: 34279767
[TBL] [Abstract][Full Text] [Related]
30. Management of vaccinations in patients with non-Hodgkin lymphoma.
Merli M; Costantini A; Tafuri S; Bavaro DF; Minoia C; Meli E; Luminari S; Gini G
Br J Haematol; 2024 May; 204(5):1617-1634. PubMed ID: 38532527
[TBL] [Abstract][Full Text] [Related]
31. COVID-19 vaccination in cancer patients: Is it the time or should we wait?
Arambulo S; Cabezas-Camarero S; Rojas H; Sotelo MJ
J Cancer Res Ther; 2021; 17(6):1588-1589. PubMed ID: 34916405
[No Abstract] [Full Text] [Related]
32. COVID-19 Vaccination for Persons with Parkinson's Disease: Light at the End of the Tunnel?
Bloem BR; Trenkwalder C; Sanchez-Ferro A; Kalia LV; Alcalay R; Chiang HL; Kang UJ; Goetz C; Brundin P; Papa SM
J Parkinsons Dis; 2021; 11(1):3-8. PubMed ID: 33523021
[TBL] [Abstract][Full Text] [Related]
33. Immunogenicity and safety of SARS-CoV-2 vaccines in clinical trials.
Lim HX; Arip M; Yahaya AAA; Jazayeri SD; Poppema S; Poh CL
Front Biosci (Landmark Ed); 2021 Nov; 26(11):1286-1304. PubMed ID: 34856768
[TBL] [Abstract][Full Text] [Related]
34. Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.
Nanduri S; Pilishvili T; Derado G; Soe MM; Dollard P; Wu H; Li Q; Bagchi S; Dubendris H; Link-Gelles R; Jernigan JA; Budnitz D; Bell J; Benin A; Shang N; Edwards JR; Verani JR; Schrag SJ
MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1163-1166. PubMed ID: 34437519
[TBL] [Abstract][Full Text] [Related]
35. Doctor-Should I get the COVID-19 vaccine? Infection and immunization in individuals with neuromuscular disorders.
Živković SA; Gruener G; Narayanaswami P;
Muscle Nerve; 2021 Mar; 63(3):294-303. PubMed ID: 33471383
[TBL] [Abstract][Full Text] [Related]
36. Low titers of SARS-CoV-2 neutralizing antibodies after first vaccination dose in cancer patients receiving checkpoint inhibitors.
Terpos E; Zagouri F; Liontos M; Sklirou AD; Koutsoukos K; Markellos C; Briasoulis A; Papanagnou ED; Trougakos IP; Dimopoulos MA
J Hematol Oncol; 2021 May; 14(1):86. PubMed ID: 34059088
[TBL] [Abstract][Full Text] [Related]
37. Cancer and COVID-19 vaccines: a complex global picture.
Yusuf A; Sarfati D; Booth CM; Pramesh CS; Lombe D; Aggarwal A; Bhoo-Pathy N; Tsunoda A; Vanderpuye V; Kutluk T; Sullivan A; Mukherji D; Mutebi M; van Hemelrijck M; Sullivan R;
Lancet Oncol; 2021 Jun; 22(6):749-751. PubMed ID: 33930324
[No Abstract] [Full Text] [Related]
38. [COVID-19 Vaccination for Cancer Patients: Progress and Preliminary Recommendations].
Wang L; Xu Y; Zhang L; Fan J; Pan R; Wang J; Wang M
Zhongguo Fei Ai Za Zhi; 2021 Jun; 24(6):377-383. PubMed ID: 34024060
[TBL] [Abstract][Full Text] [Related]
39. India begins COVID-19 vaccination amid trial allegations.
Bhuyan A
Lancet; 2021 Jan; 397(10271):264. PubMed ID: 33485435
[No Abstract] [Full Text] [Related]
40. Spanish Society of Hematology and Hemotherapy expert consensus opinion for SARS-CoV-2 vaccination in onco-hematological patients.
Piñana JL; Vázquez L; Martino R; de la Cámara R; Sureda A; Rodríguez-Veiga R; Garrido A; Sierra J; Ribera JM; Torrent A; Mateos MV; de la Rubia J; Tormo M; Díez-Campelo M; García-Gutiérrez V; Álvarez-Larrán A; Sancho JM; MartínGarcía-Sancho A; Yañez L; Pérez Simón JA; Barba P; Abrisqueta P; Álvarez-Twose I; Bonanad S; Lecumberri R; Ruiz-Camps I; Navarro D; Hernández-Rivas JÁ; Cedillo Á; García-Sanz R; Bosch F
Leuk Lymphoma; 2022 Mar; 63(3):538-550. PubMed ID: 34668835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
